These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18648616)

  • 1. Universality of J-shaped and U-shaped dose-response relations as emergent properties of stochastic transition systems.
    Cox LA
    Dose Response; 2006 May; 3(3):353-68. PubMed ID: 18648616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing the Risk Paradigms Can be Good for Our Health: J-Shaped, Linear and Threshold Dose-Response Models.
    Ricci PF; Straja SR; Cox AL
    Dose Response; 2012; 10(2):177-89. PubMed ID: 22740780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk assessment of nongenotoxic carcinogens based upon cell proliferation/death rates in rodents.
    Gaylor DW; Zheng Q
    Risk Anal; 1996 Apr; 16(2):221-5. PubMed ID: 8638041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormesis without cell killing.
    Cox LA
    Risk Anal; 2009 Mar; 29(3):393-400. PubMed ID: 18793280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of experimental and theoretical parameters of the Moolgavkar-Venzon-Knudson incidence function for the stages of initiation and promotion in rat hepatocarcinogenesis.
    Dragan YP; Hully J; Baker K; Crow R; Mass MJ; Pitot HC
    Toxicology; 1995 Sep; 102(1-2):161-75. PubMed ID: 7482551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Threshold dose response for tumor induction by genotoxic carcinogens modeled via cell-cycle delay.
    Lutz WK; Kopp-Schneider A
    Toxicol Sci; 1999 May; 49(1):110-5. PubMed ID: 10367348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Armitage-Doll two-stage model: implications and extension.
    Chen CW
    Risk Anal; 1993 Jun; 13(3):273-9. PubMed ID: 8341806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consideration of tissue response in the application of the two-mutation model to radiation carcinogenesis.
    Holt PD
    Int J Radiat Biol; 1997 Feb; 71(2):203-13. PubMed ID: 9120356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporating additional biological phenomena into two-stage cancer models.
    Sielken RL; Bretzlaff RS; Stevenson DE
    Prog Clin Biol Res; 1994; 387():237-60. PubMed ID: 7972250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are two mutations sufficient to cause cancer? Some generalizations of the two-mutation model of carcinogenesis of Moolgavkar, Venzon, and Knudson, and of the multistage model of Armitage and Doll.
    Little MP
    Biometrics; 1995 Dec; 51(4):1278-91. PubMed ID: 8589222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation as a Cancer Co-Initiator: New Mechanistic Model Predicts Low/Negligible Risk at Noninflammatory Carcinogen Doses.
    Bogen KT
    Dose Response; 2019; 17(2):1559325819847834. PubMed ID: 31205456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An exact analysis of the multistage model explaining dose-response concavity.
    Cox LA
    Risk Anal; 1995 Jun; 15(3):359-68. PubMed ID: 7604169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response relationships in chemical carcinogenesis: superposition of different mechanisms of action, resulting in linear-nonlinear curves, practical thresholds, J-shapes.
    Lutz WK
    Mutat Res; 1998 Sep; 405(2):117-24. PubMed ID: 9748532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stochastic thresholds: a novel explanation of nonlinear dose-response relationships for stochastic radiobiological effects.
    Scott BR
    Dose Response; 2006 May; 3(4):547-67. PubMed ID: 18648632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogenic risk assessment with time-dependent exposure patterns.
    Murdoch DJ; Krewski D
    Risk Anal; 1988 Dec; 8(4):521-30. PubMed ID: 3244859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An exact representation for the generating function for the Moolgavkar-Venzon-Knudson two-stage model of carcinogenesis with stochastic stem cell growth.
    Denes J; Krewski D
    Math Biosci; 1996 Jan; 131(2):185-204. PubMed ID: 8589544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population risk and physiological rate parameters for colon cancer. The union of an explicit model for carcinogenesis with the public health records of the United States.
    Herrero-Jimenez P; Tomita-Mitchell A; Furth EE; Morgenthaler S; Thilly WG
    Mutat Res; 2000 Jan; 447(1):73-116. PubMed ID: 10686307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A stochastic carcinogenesis model incorporating multiple types of genomic instability fitted to colon cancer data.
    Little MP; Vineis P; Li G
    J Theor Biol; 2008 Sep; 254(2):229-38. PubMed ID: 18640693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk assessment of 2,3,7,8-TCDD using a biologically based cancer model: a reevaluation of the Kociba et al. bioassay using 1978 and 1990 histopathology criteria.
    Paustenbach DJ; Layard MW; Wenning RJ; Keenan RE
    J Toxicol Environ Health; 1991 Sep; 34(1):11-26. PubMed ID: 1653856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation, cell kinetics, and subpopulations at risk for colon cancer in the United States.
    Herrero-Jimenez P; Thilly G; Southam PJ; Tomita-Mitchell A; Morgenthaler S; Furth EE; Thilly WG
    Mutat Res; 1998 May; 400(1-2):553-78. PubMed ID: 9685710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.